{"id":1623,"date":"2020-03-12T15:15:10","date_gmt":"2020-03-12T14:15:10","guid":{"rendered":"http:\/\/oncngs.eu\/?page_id=1623"},"modified":"2021-04-14T15:19:59","modified_gmt":"2021-04-14T13:19:59","slug":"tender","status":"publish","type":"page","link":"https:\/\/oncngs.eu\/index.php\/tender\/","title":{"rendered":"Pre-commercial Procedure"},"content":{"rendered":"<p>[vc_row][vc_column][vc_column_text]<\/p>\n<p style=\"font-family: Rubik; color: black;\">The pre-commercial procurement procedure consists of three clearly defined phases: Solution design, Prototype development and Clinical validation of a limited scale pre-commercial devices (see graphic below).<\/p>\n<p style=\"font-family: Rubik; color: black;\"><strong>Phase 1 &#8211; Solution design<\/strong>:\u00a0 concepts elaboration into the competitive solutions. Minimum 4 designs\u00a0will be selected.<\/p>\n<p style=\"font-family: Rubik; color: black;\"><strong>Phase 2 &#8211; Prototype development<\/strong>:\u00a0 development of the well outlined and functioning prototypes. Minimum 3 designs will be selected.<\/p>\n<p style=\"font-family: Rubik; color: black;\"><strong>Phase 3 &#8211; Clinical validation of a limited scale pre-commercial devices<\/strong><strong>:<\/strong>\u00a0 the functional and technical properties of the selected solutions will be evaluated in an operational environment. Minimum of 2 pre-commercial devices will be deployed.<\/p>\n<figure id=\"attachment_1769\" aria-describedby=\"caption-attachment-1769\" style=\"width: 1024px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-1769 size-large\" src=\"https:\/\/oncngs.eu\/wp-content\/uploads\/2020\/07\/WP_oncngs-e1617716673629-1024x509.png\" alt=\"\" width=\"1024\" height=\"509\" srcset=\"https:\/\/oncngs.eu\/wp-content\/uploads\/2020\/07\/WP_oncngs-e1617716673629-1024x509.png 1024w, https:\/\/oncngs.eu\/wp-content\/uploads\/2020\/07\/WP_oncngs-e1617716673629-300x149.png 300w, https:\/\/oncngs.eu\/wp-content\/uploads\/2020\/07\/WP_oncngs-e1617716673629-768x382.png 768w, https:\/\/oncngs.eu\/wp-content\/uploads\/2020\/07\/WP_oncngs-e1617716673629-1536x764.png 1536w, https:\/\/oncngs.eu\/wp-content\/uploads\/2020\/07\/WP_oncngs-e1617716673629-600x298.png 600w, https:\/\/oncngs.eu\/wp-content\/uploads\/2020\/07\/WP_oncngs-e1617716673629.png 1916w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><figcaption id=\"caption-attachment-1769\" class=\"wp-caption-text\">Phases of OncNGS PCP<\/figcaption><\/figure>\n<p>[\/vc_column_text][vc_btn title=\u00a0\u00bbContact us\u00a0\u00bb style=\u00a0\u00bbflat\u00a0\u00bb shape=\u00a0\u00bbsquare\u00a0\u00bb color=\u00a0\u00bbgreen\u00a0\u00bb align=\u00a0\u00bbcenter\u00a0\u00bb link=\u00a0\u00bburl:http%3A%2F%2Foncngs.eu%2Findex.php%2Fcontact-us%2F|title:Submit||\u00a0\u00bb][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator color=\u00a0\u00bbgreen\u00a0\u00bb][vc_column_text]<\/p>\n<h1>Other phases<\/h1>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_btn title=\u00a0\u00bbPhase 0 : Curiosity Driven Research\u00a0\u00bb align=\u00a0\u00bbleft\u00a0\u00bb link=\u00a0\u00bburl:http%3A%2F%2Foncngs.eu%2Findex.php%2Fphase-0-curiosity-driven-research%2F|title:Phase%20I%20%3A%20Solution%20design||\u00a0\u00bb][vc_empty_space height=\u00a0\u00bb2px\u00a0\u00bb][vc_btn title=\u00a0\u00bbPhase I : Solution design\u00a0\u00bb align=\u00a0\u00bbleft\u00a0\u00bb link=\u00a0\u00bburl:http%3A%2F%2Foncngs.eu%2Findex.php%2Fphase1%2F|title:Phase%20I%20%3A%20Solution%20design||\u00a0\u00bb][vc_empty_space height=\u00a0\u00bb2px\u00a0\u00bb][vc_btn title=\u00a0\u00bbPhase II: Prototype development\u00a0\u00bb align=\u00a0\u00bbleft\u00a0\u00bb link=\u00a0\u00bburl:http%3A%2F%2Foncngs.eu%2Findex.php%2Fphase2%2F|title:Phase%20II%3A%20Prototyping%20and%20Analytical%20testing||\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1617717243599{border-radius: 20px !important;}\u00a0\u00bb][vc_empty_space height=\u00a0\u00bb2px\u00a0\u00bb][vc_btn title=\u00a0\u00bbPhase III : Clinical validation of a limited set of pre-commercial devices \/ Clinical testing\u00a0\u00bb align=\u00a0\u00bbleft\u00a0\u00bb link=\u00a0\u00bburl:http%3A%2F%2Foncngs.eu%2Findex.php%2Fphase3%2F|title:Phase%20III%20%3A%20Clinical%20validation%20of%20a%20limited%20set%20of%20pre-commercial%20devices%20%2F%20Clinical%20testing||\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1600943153477{border-radius: 20px !important;}\u00a0\u00bb][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"[vc_row][vc_column][vc_column_text] The pre-commercial procurement procedure consists of three clearly defined phases: Solution design, Prototype development and Clinical validation of a limited scale pre-commercial devices (see graphic below). Phase 1 &#8211; Solution design:\u00a0 concepts elaboration into the competitive solutions. Minimum 4 designs\u00a0will be selected. Phase 2 &#8211; Prototype development:\u00a0 development of the well outlined and functioning[&#8230;]","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/oncngs.eu\/index.php\/wp-json\/wp\/v2\/pages\/1623"}],"collection":[{"href":"https:\/\/oncngs.eu\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/oncngs.eu\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/oncngs.eu\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/oncngs.eu\/index.php\/wp-json\/wp\/v2\/comments?post=1623"}],"version-history":[{"count":35,"href":"https:\/\/oncngs.eu\/index.php\/wp-json\/wp\/v2\/pages\/1623\/revisions"}],"predecessor-version":[{"id":2087,"href":"https:\/\/oncngs.eu\/index.php\/wp-json\/wp\/v2\/pages\/1623\/revisions\/2087"}],"wp:attachment":[{"href":"https:\/\/oncngs.eu\/index.php\/wp-json\/wp\/v2\/media?parent=1623"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}